Is Firefly Neuroscience, Inc. (AIFF) a Buy, Sell, or Hold?
NASDAQ : AIFF
Firefly Neuroscience, Inc.
$1.13 USD
-$0.02 (-1.74%)
- Volume
- 38.15K
- Average Volume
- 419.74K
- Market Capitalization
- $17.63M
- P/E Ratio
- -1.66
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.63
- Year Low
- $0.62
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.82
| Source | Headline |
|---|---|
|
Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company advancing precision neuroscience, today announced the identification of a novel electrophysiological biomarker for Post-Traumatic Stress Disorder (“PTSD”) using brain scans collected on its FDA-510(k)-cleared Evoke System. The biomarker discovery emanates partly from Firefly's previously announced public-private partnership with the U.S. Department of War (“DoW”) to support the assessment and treatment of active-duty U.S. service members and veterans suffering from PTSD and/or Traumatic Brain Injury (“TBI”). globenewswire.com - 2026-06-02 07:40:00 |
|
Short Interest in Firefly Neuroscience, Inc. (NASDAQ:AIFF) Declines By 14.6%
Firefly Neuroscience, Inc. (NASDAQ: AIFF - Get Free Report) was the recipient of a large decline in short interest during the month of March. As of March 31st, there was short interest totaling 1,324,628 shares, a decline of 14.6% from the March 15th total of 1,551,962 shares. Currently, 9.6% of the company's shares are sold short. defenseworld.net - 2026-04-17 01:36:44 |
